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We investigated a cluster of community-associated
methicillin-resistant  Staphylococcus aureus infections
among persons at a wilderness canoe camp. Isolates from
the investigation had identical  profiles for susceptibility,
pulsed-field gel electrophoresis, and toxins. Participants in
activities that involve skin injury, person-to-person contact,
and inadequate hygiene are at increased risk for methi-
cillin-resistant S. aureus infections.
I
n 2000, the Minnesota Department of Health (MDH) ini-
tiated prospective active surveillance at 12 sentinel hos-
pitals for community-associated methicillin-resistant
Staphylococcus aureus (CA-MRSA) infections. Cases are
classified as CA-MRSA if the patient lacks traditional
healthcare-associated risk factors (hospitalization, surgery,
dialysis, residence in a long-term care facility during the
year before culture, or having an indwelling device at the
time of culture). Although >80% of CA-MRSA infections
involve skin or soft tissue, invasive disease that involves
bones, joints, and sepsis can occur (1,2). During
2000–2004, 2% of CA-MRSA cases reported to MDH
were joint infections.
Outbreaks of CA-MRSA have been associated with
sports that require physical contact and result in frequent
damage to skin (3,4) and with crowded settings (e.g., cor-
rectional facilities, military settings), where access to
hygiene measures is limited (5,6). In response to a case
cluster of CA-MRSA infections at a wilderness canoe
camp, MDH performed an investigation to identify addi-
tional cases; MRSA colonization among staff, campers,
and household members; and risk factors for infection.
The Study
In August 2004, MDH was notified of 2 previously
healthy 15-year-old male patients who were hospitalized
for septic arthritis caused by MRSA; 1 had required
treatment in an intensive care unit. The patients had been
in the same group that participated in a 21-day wilderness
canoe trip in northern Minnesota, USA. A third case-
patient, a previously healthy 17-year-old female camper
who had participated in an earlier 21-day trip and had had
a skin infection without complications, was identified dur-
ing the investigation (Table).
Acase was defined as a clinically relevant, culture-con-
firmed, MRSA infection that occurred between June 1 and
September 30, 2004, in a staff member, camper, or mem-
ber of a camper’s household. Colonization was defined as
MRSA identified from the nares of these persons in the
absence of MRSA infection. 
MDH and local public health staff investigated the base
camp. During the 21-day canoeing trip, participants spent
1 day at base camp at the beginning and end of the trip; the
remaining time was spent canoeing, portaging, and camp-
ing on the trail. Camping groups were composed of 5–6
campers and a guide. Campers were of the same sex and
were 15–17 years old. Campers and guides shared a com-
mon tent and did all activities together, but each had his or
her own sleeping bag and towels. Campers and guides did
not have access to running water or soap outside of base
camp; the information on the wilderness area permit dis-
courages use of soap, including biodegradable soap, with-
in 150 feet of water.
Campers who had participated in the same, concurrent,
or preceding canoe trips with the same itinerary and their
household members were interviewed regarding health
history, skin infections and injury, hygiene, clothing,
camping behavior, and contact with other campers. Swabs
of anterior nares were obtained from consenting staff,
campers, and members of campers’ households and were
submitted to the MDH Public Health Laboratory. Isolates
were identified by standard methods. Susceptibility testing
was conducted by broth microdilution (PML
Microbiology, Wilsonville, OR, USA) and interpreted
according to Clinical and Laboratory Standards Institute
(formerly NCCLS) criteria. Pulsed-field gel electrophore-
sis (PFGE) was performed by digestion with the restriction
enzyme SmaI (7). Patterns were compared visually and
with Bionumeric software (Applied Maths, Kortrijk,
Belgium) to reference strains of S. aureus (8). Sequences
encoding toxin genes (TSST-1, Panton-Valentine leuko-
cidin, sea, seb, sec, and sed) were detected by PCR (9,10).
Univariate analysis was conducted with EpiInfo version
6.04 (Centers for Disease Control and Prevention, Atlanta,
GA, USA) using a significance level of p<0.05. 
Of 21 campers, 19 (90%) were interviewed. The 2 case-
patients had occasionally shared the same canoe. All
campers reported having had frequent skin injuries, includ-
ing insect bites, cuts, burns, blisters, and abrasions, during
their trips. Campers reported having worn shorts most of
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shoes. No differences were identified between campers
with and without CA-MRSA or between camping groups
with and without CA-MRSAin terms of health history, use
of antimicrobial drugs during the past year, skin infections
and injury, hygiene, clothing, or camping behavior.
Interviews were also conducted with 55 camper household
members, representing 19 households. Members of 2
households could not be reached, and no information was
obtained on the number of persons in these households.
Interview responses of household members of case-
patients did not differ from those of household members of
the other campers and staff. No case-patient or colonized
person reported a history of MRSA infection or coloniza-
tion. One camper who was not a case-patient reported hav-
ing had a positive blood culture for CA-MRSAin the prior
year; this camper had been hospitalized with an infection
that began as cellulitis and resulted in septic shock and was
found to be not colonized at the time of the investigation.
Also, the camp director informed MDH that in the prior
year, 2 counselors had been treated for apparent spider
bites at a local clinic; however, cultures had not been
obtained.
Nares swabs were obtained for case-patients 2 and 3 but
not case-patient 1 because he was receiving nasal
mupirocin treatment. None of the case-patients was colo-
nized with MRSA. Nares swabs were also obtained for
62% of campers without MRSA infection; of these, 1
female camper who had participated in a preceding trip
was found to be colonized with MRSA. Swabs obtained
from the anterior nares of 16 camp guides and base camp
staff members showed MRSA colonization in 1. This staff
member had not gone on any camping trips with the case-
patients. Of nares swabs from 40 household members
(including all 8 household members of case-patients), none
was positive for MRSA.
All 5 MRSA isolates (from the 3 case-patients and the
2 colonized persons) were susceptible to clindamycin,
ciprofloxacin, erythromycin, gentamicin, linezolid, quino-
pristin/dalfopristin, rifampin, tetracycline, trimethoprim/
sulfamethoxazole, and vancomycin and had an MIC for
mupirocin of <4 µg/mL. The isolates were USA400
pulsed-field type and were indistinguishable by PFGE (8).
The isolate from the camper who had had an MRSAinfec-
tion in 2003 was also indistinguishable by PFGE. All 2004
isolates contained genes encoding Panton-Valentine leuko-
cidin, sea, and sec (10).
To prevent further infections, camp staff were given
information about S. aureus, MRSA, and infection-preven-
tion measures. Campers were instructed to wear long pants
when possible, protect skin from injury (e.g., use insect
repellent), report all suspected skin infections promptly,
keep skin as clean as possible, use alcohol-based hand san-
itizers, and not share personal items like towels and cloth-
ing. Frequently touched surfaces were cleaned with a
bleach solution, and life vests were assigned to individual
campers and disinfected between campers.
Conclusions
CA-MRSAinfections are increasingly reported and can
be severe. Despite multiple outbreaks attributed to
USA300, only a few reported case clusters have been
caused by USA400 (11,12). USA400 does contain viru-
lence factors, and although most cases have been mild skin
and soft tissue infections, some have been severe and fatal
(13). Furthermore, although the colonization rate was low
DISPATCHES
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higher than CA-MRSA colonization rates for the general
population (14), as would be expected for case-patient
contacts. S. aureus (including CA-MRSA) spreads easily
among people in crowded settings, particularly when ade-
quate hygiene cannot be maintained, both of which
occurred in this camping setting.
Although anecdotal, suspected, and confirmed cases
during the prior year are consistent with ongoing transmis-
sion associated with the camp, that spider bites were
reported is noteworthy because CA-MRSA infections are
often misdiagnosed as spider bites (15). Injuries and
breaks in skin should be closely monitored in settings
where medical care is not readily available. Methods for
skin protection and hygiene should be developed and
implemented for populations in settings where CA-MRSA
transmission and infection can be anticipated.
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